Related Experiment Videos
A discrete sequence in a platelet integrin is involved in ligand recognition
S E D'Souza1, M H Ginsberg, G R Matsueda
1Committee on Vascular Biology, Research Institute of Scripps Clinic, La Jolla, California 92037.
Nature
|March 7, 1991
Summary
An 11-residue peptide from platelet glycoprotein IIb-IIIa (gpIIb-IIIa) inhibits fibrinogen binding and platelet aggregation. This finding highlights a key region in gpIIb-IIIa
Area of Science:
- Biochemistry
- Cell Biology
- Integrin Biology
Background:
- Platelet membrane glycoprotein IIb-IIIa (gpIIb-IIIa) is a key integrin receptor mediating platelet aggregation.
- It binds fibrinogen, a critical step in thrombosis and hemostasis.
- A specific amino-acid sequence on fibrinogen's gamma chain is recognized by gpIIb-IIIa.
Purpose of the Study:
- To investigate the role of a specific region of gpIIb-IIIa in ligand binding and platelet function.
- To determine if a peptide from this region can inhibit platelet aggregation and fibrinogen binding.
Main Methods:
- Synthesized an 11-residue peptide from a specific region of gpIIb.
- Tested the peptide's ability to inhibit platelet aggregation.
- Assessed the peptide's effect on fibrinogen binding to platelets and purified gpIIb-IIIa.
- Investigated direct interaction between the peptide and fibrinogen.
Main Results:
- The 11-residue peptide from gpIIb significantly inhibited platelet aggregation.
- The peptide blocked fibrinogen binding to both platelets and purified gpIIb-IIIa.
- Direct interaction was observed between the peptide and fibrinogen.
- The implicated gpIIb-IIIa segment plays a crucial role in receptor-ligand interactions.
Conclusions:
- A specific segment of gpIIb-IIIa is directly involved in fibrinogen binding and platelet aggregation.
- This region's conservation across integrins suggests a general role in ligand recognition for this receptor family.
- Findings provide insights into the molecular mechanisms of platelet function and thrombosis.